Keyword: Salix Pharmaceuticals
Bausch Health's Salix loses president McKenna; Bayer nabs dealmaker De Backer from J&J; AltaSciences nabs Charles River exec LeSauteur.
The Bausch Health subsidiary plans to trial the ex-Biogen S1P receptor functional antagonist in ulcerative colitis.
Lucemyra, which has been used for more than two decades in the U.K., was approved to help make opioid withdrawal easier for U.S. patients.
Troubled Canadian specialty pharma company Valeant has won U.S. approval for a new oral formulation of the previously injectable-only med Relistor for certain forms of constipation in what could push the drug into blockbuster territory.